Accelerated Early Phase Decision-Making – Insider Insights to Speed Development

Published on: Jan 7, 2025

Access insider insights from combined perspectives of clinical pharmacology, global regulatory considerations, and private equity investors on accelerating early development timelines to go/no go decisions and early proof of concept, without shortcuts. Parexel’s early phase team and EQT LifeSciences share best practices for combining sequential early phase studies into a single protocol.

Return to Insights Center

Related Insights

Related Insights

Blog

Regulatory outsourcing: Applying change management best practices for smoother transitions

Jul 24, 2025

Playbook

Streamlining development in the EU: Strategies for smoother CTA submissions

Feb 27, 2025

Article

How a joined-up development strategy pays off for early-stage biotechs

May 19, 2021

Article

Maximize the efficiency of regulatory operations with five key competencies

Jul 23, 2021

Article

Expedited Pathways Comparisons - US EU CHN

Oct 19, 2021

Video

Overcoming asset transfer challenges during a merger and acquisition (M&A)

Oct 20, 2021

Show more